Delivery Order SPE2DB22D2206-SPE2DB24FJK98

Award Date 7/25/24
Potential Completion Date 7/26/24
Potential Value $4.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution company. The contract is for the delivery of Rifampin 300 mg capsules and has a ceiling value of $65,431.34. The contract has an ultimate completion date of February 29, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical, valued at up to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,160,692 units of Rifampin 300 mg capsules. The contract has a ceiling value of $5,109.58 and a period of performance through May 7, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Rifampin 300 mg capsules, a prescription medication, with a ceiling value of $2,236.36 and a period of performance through June 26, 2025. The contract is a firm-fixed price delivery order, with no set-aside designation, indicating open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Rifampin 300 mg capsules, a pharmaceutical product used to treat various bacterial infections. The contract has a ceiling value of $17,234.83 and a period of performance through March 25, 2025. It is a firm fixed-price contract, without any set-aside designation. AmerisourceBergen...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Rifampin 300 mg capsules, a medication used to treat infectious diseases. The contract has a ceiling value of $2,401.32 and runs through February 7, 2025. It is a firm-fixed-price contract, and there is no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Rifampin 300 mg capsules and has a ceiling value of $25,897.67. The contract is a Firm Fixed Price, non-set-aside award with a performance period ending on May 2, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $22,680.36, is for the delivery of Rifampin 300 mg capsules. The contract has an ultimate completion date of June 14, 2024 and is a firm fixed-price contract. The contract is not associated with a set-aside program. It is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Rifampin 300 mg capsules, a medication used to treat various bacterial infections. The contract has a ceiling value of $17,230.68 and an ultimate completion date of April 19, 2023. The contract is a firm fixed-price arrangement, and there was no set-aside designation used in the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the delivery of Rifampin 300 mg capsules, a critical antibiotic medication, to support military treatment facilities and other government healthcare programs. The contract has a total ceiling value of $16,365.64 and is a firm fixed-price, delivery order type contract with a period of performance through September...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of RIFAMPIN 300 MG CAPSULE 60S, a prescription medication, with a ceiling value of $2,748.52 and a period of performance through May 28, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FJK98
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Rifampin 300 mg capsules. The contract has a ceiling value of $4,437.23 and a performance period that runs until July 26, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a wide range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 10/27/24, 2:55 AM